Levobupivacaine

ADVERTISEMENT

Identification

Molecular formula
C18H28N2O2
CAS Number
27262-48-2
IUPAC Name
propyl 4-[[2-(cyclohexylamino)acetyl]amino]-3,5-dimethyl-benzoate
Molecular Weight
324.47g/mol
Melting Point
(Celsius)
Boiling Point
(Celsius)
Density
0.9280g/cm3
Appearance
can also be described as a dry solid at room temperature.
Synonyms
BRN 2396651
Interesting facts

Interesting Facts about Propyl 4-[[2-(cyclohexylamino)acetyl]amino]-3,5-dimethyl-benzoate

Propyl 4-[[2-(cyclohexylamino)acetyl]amino]-3,5-dimethyl-benzoate is a fascinating compound that belongs to the class of benzoate esters. It possesses unique structural features that contribute to its potential applications in various fields, particularly in medicinal chemistry.

Key Highlights:

  • Pharmacological Potential: Compounds similar to this one have shown promise in pharmaceutical research, particularly as they may exhibit anti-inflammatory and analgesic properties.
  • Structural Diversity: The presence of both cyclohexylamine and a 3,5-dimethyl substitution pattern on the benzoate ring enhances the structural diversity, providing opportunities for the development of novel therapeutic agents.
  • Applications: This compound's unique combination of functional groups makes it a candidate for drug design, potentially leading to effective treatments for diseases associated with pain and inflammation.
  • Chemical Synthesis: The synthesis of propyl 4-[[2-(cyclohexylamino)acetyl]amino]-3,5-dimethyl-benzoate involves multiple steps and requires careful manipulation of reagents to achieve the desired purity and yield.

As a compound that integrates elements from both organic chemistry and pharmacology, propyl 4-[[2-(cyclohexylamino)acetyl]amino]-3,5-dimethyl-benzoate exemplifies the importance of structure-activity relationships in drug discovery. Understanding how variations in molecular structure can influence biological activity is crucial for researchers looking to innovate in the world of medicinal chemistry.

In conclusion, the study of compounds like this allows scientists to push the boundaries of current pharmaceutical knowledge and explore new therapeutic avenues, potentially leading to breakthroughs in drug development.

ADVERTISEMENT